Abstract
The comparative characteristic of application of statins in combination with fibrates and omega-3 polyunsaturated fatty acids in patients with coronary heart disease and type 2 diabetes mellitus were hold in the article. The study included 75 patients with CHD and type 2 diabetes mellitus, who were divided into two subgroups depending on the received lipid-lowering therapy. The first subgroup included 37 patients with coronary heart disease and concomitant type 2 diabetes mellitus, who in order to low the lipid level received atorvastatin in dose of 20 mg per day and fenofibrate at a dose of 14 mg per day after dinner. The second subgroup included 38 patients with the same nosological units who received atorvastatin in dose of 20 mg / day and omega-3 polyunsaturated fatty acids at a dose of 1000 mg in the morning and in the evening. The study demonstrated a positive effect of combinations of lipid-lowering therapy on lipid metabolism in the form of atorvastatin with fibrates and omega-3 polyunsaturated fatty acids in patients with coronary heart disease and type 2 diabetes mellitus due to the reduction of atherogenic fractions and increase of proatherogenic ones. According to the results of our study any significant differences of lipidogram depending on the lipid-lowering therapy schemes (atorvastatin and fibrates; atorvastatin and omega-3 polyunsaturated fatty acids) in patients with coronary artery disease and type 2 diabetes mellitus has not been established, but there was a trend to increase the level of HDL cholesterol in patients treated with omega-3 polyunsaturated fatty acids in addition to statin and to reduce TG in patients treated with fibrates in combination with statins.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
